Videos

Dr Robert Busch and Dr Muthiah Vadugananthan provide insights on educating their peers on the importance of decreasing renal progression.

Importance of Education on Reducing Renal Progression

An expert endocrinologist and cardiologist discuss the risks and complications of renal disease associated with diabetes and cardiovascular disease. Dr Robert Busch also provides an overview of some of the studies done in renal impairment.

Risks and Complications for Chronic Kidney Disease

Dhiren Patel, PharmD, CECES, BC-ADM, Robert Busch, MD, and Muthiah Vadugananthan, MD, MPH, provide an overview of the prevalence of renal impairment in patients with diabetes.

Overview of Diabetes and Renal Impairment

Patrick Campbell is the senior editor of Endocrinology Network, as well as its sister publication Practical Cardiology. Prior to joining these brands, he led coverage of cardiology and diabetes with HCPLive. Before joining parent company MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a freelance multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record. In his free time, he enjoys traveling, sports, and exploring the great outdoors. Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Erica P. Gunderson, PhD, MS, MPH, offers perspective on the current state of gestational diabetes management as well as avenues for improving current diagnostic and management standards. 

Improving Awareness and Management of Gestational Diabetes, With Erica Gunderson, PhD

Vivian Fonseca, MD, reflects on the 100-year anniversary of the discovery of insulin and how the role of insulin has evolved since Sir Frederick Banting's historic discovery. 

Reflecting on 100 Years of Insulin, With Vivian Fonseca, MD

Silvio Inzucchi, MD, discusses his presentation on the role of diabetes medications, including SGLT2 inhibitors and GLP-1 RAs, in stroke prevention from TMIOA's 5th Heart in Diabetes conference. 

Silvio Inzucchi, MD: Stroke Prevention and Diabetes Medications

Diana Isaacs, PharmD, a clinical pharmacy specialist, and Lucia Novak, CRNP, a nurse practitioner, have a discussion centered around how Walmart's recent launch of ReliOn NovoLog impacts the landscape of diabetes management and insulin affordability. 

How Walmart and Novo Nordisk's Insulin Initiative Impacts Insulin Affordability, With Diana Isaacs, PharmD, and Lucia Novak, CRNP

Juan Frias, MD, breaks down results of a post-hoc analysis of the AWARD-11 study examining expanded doses of dulaglutide according to baseline HbA1c levels.

Expanded Doses of Dulaglutide Safe, Efficacious Regardless of Baseline HbA1c

Learn more about once-weekly basal insulin Fc from Eli Lilly and Company in this interview with the lead investigator from their phase 2 trial, which was presented at ENDO 2021.

Once-Weekly Basal Insulin Fc Shows Promise in Phase 2 Trial

Principal investigator of the SURPASS-2 trial discusses the results of the trial and how it informs clinicians on the use of tirzepatide versus currently approved diabetes medications. 

Expert Interviews